HeXun Biosciences Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021
Period Ending	Apr '25 Apr 1, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,781	2,981	-	-
Enterprise Value	3,443	2,763	-	-
Last Close Price	82.20	64.80	-	-
PE Ratio	25.69	89.01	-	-
PS Ratio	13.20	22.83	-	-
PB Ratio	6.09	6.30	-	-
P/TBV Ratio	6.58	6.79	-	-
P/FCF Ratio	45.22	132.95	-	-
P/OCF Ratio	51.29	69.18	-	-
EV/Sales Ratio	12.02	21.16	-	-
EV/EBITDA Ratio	19.08	64.08	-	-
EV/EBIT Ratio	22.11	100.94	-	-
EV/FCF Ratio	41.17	123.24	-	-
Debt / Equity Ratio	0.06	0.15	0.23	0.35
Debt / EBITDA Ratio	0.25	1.56	13.75	-
Debt / FCF Ratio	1.12	3.24	7.16	-
Asset Turnover	0.42	0.27	0.14	-
Quick Ratio	12.11	11.67	9.82	10.87
Current Ratio	12.69	12.05	10.55	11.94
Return on Equity (ROE)	25.42%	8.50%	-1.96%	-
Return on Assets (ROA)	12.81%	3.51%	-1.61%	-
Return on Capital (ROIC)	13.38%	3.67%	-1.66%	-
Return on Capital Employed (ROCE)	20.00%	5.10%	-	-
Earnings Yield	3.89%	1.12%	-	-
FCF Yield	2.21%	0.75%	-	-
Buyback Yield / Dilution	-10.22%	-20.81%	-22.92%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.